Clinical Trial Update: Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial update on etanercept for treating idiopathic pneumonia syndrome after donor stem cell transplant in young patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pneumonia Syndrome

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Children's Oncology Group | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-02-14